New fluid strategy aims to reduce organ failure in septic shock
NCT ID NCT03461900
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a personalized approach to fluid management in 535 adults with septic shock. Doctors used a 'mini-fluid challenge'—a small amount of albumin given quickly—to check if more fluids would help, aiming to avoid fluid overload. The goal was to see if this tailored method could reduce organ failure compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- mini-fluid challenge (100 ml of 4% human serum albumin)
- What this could lead to
- If successful, this approach could help doctors better manage fluid levels in septic shock patients, potentially reducing organ damage and improving recovery.
- What could go wrong
- This is a completed trial, but the intervention is a management strategy, not a new drug. Benefits may be modest and depend on how well it's implemented in different ICUs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Angers university hospital
Angers, France
-
Besançon university hospital
Besançon, France
-
Brest university hospital
Brest, 29200, France
-
Brest university hospital
Brest, France
-
Chartres Hospital
Chartres, 28000, France
-
Clermont Ferrand university hospital
Clermont-Ferrand, France
-
George Pompidou university hospital (APHP)
Paris, France
-
Hôpital privé de l'ouest parisen
Trappes, 78190, France
-
Kremlin Bicêtre university hospital (APHP)
Paris, France
-
Le Mans hospital
Le Mans, France
-
Marseille university horpital
Marseille, France
-
Morlaix hospital
Morlaix, France
-
Nantes university hospital
Nantes, France
-
Nîmes university hospital
Nîmes, 30029, France
-
Poitiers university hospital
Poitiers, France
-
Rouen university hospital
Rouen, France
-
Toulon hospital
Toulon, France
-
Tours university hospital
Tours, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood markers may foretell brain fog after sepsis
- Can tracking immune chaos in sepsis reveal new treatment targets?
- Blood clot score may predict organ damage in septic shock
- Could a key hormone be missing in septic shock?
- Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?
- Blood filter could shield vessels in septic shock